Dec 9, 2025 08:52AM
Nov 7, 2025 07:00AM
Oct 11, 2025 04:02AM
Oct 10, 2025 06:03AM
Oct 9, 2025 04:31PM
Oct 9, 2025 12:12PM
Oct 9, 2025 12:12PM LifeSci Capital Downgrades Akero Therapeutics (AKRO) to Market Perform
Oct 9, 2025 06:02AM
Oct 7, 2025 07:00AM
Sep 4, 2025 06:13AM
Aug 8, 2025 09:38AM
Aug 6, 2025 10:07AM
Aug 4, 2025 05:30AM
Jun 13, 2025 11:43AM Jefferies: 'We highlight multiple de-risked or commercial-stage names that we think have promising M&A potential'
May 20, 2025 01:10PM
May 13, 2025 02:26PM
May 13, 2025 06:25AM
May 13, 2025 04:52AM
May 12, 2025 02:38PM
May 9, 2025 07:15AM
May 9, 2025 06:41AM Akero Therapeutics (AKRO) Presents Week 96 Results from Phase 2b SYMMETRY Clinical Trial of Efruxifermin
Apr 30, 2025 12:41AM
Apr 2, 2025 07:04AM
Mar 3, 2025 06:15AM
Jan 29, 2025 04:08PM
Jan 28, 2025 06:35AM
Jan 28, 2025 05:02AM
Jan 27, 2025 04:01PM Akero Therapeutics (AKRO) Announces Proposed Public Offering of Common Stock
Jan 27, 2025 02:38PM
Jan 27, 2025 11:47AM
Jan 27, 2025 10:36AM
Jan 27, 2025 10:30AM
Jan 27, 2025 06:32AM
Jan 24, 2025 04:08PM
Jan 17, 2025 06:39AM H.C. Wainwright Reiterates Buy Rating on Akero Therapeutics (AKRO)
Jan 16, 2025 02:56PM
Jan 9, 2025 05:18PM
Dec 30, 2024 05:30PM
Dec 30, 2024 08:49AM
Dec 19, 2024 02:00PM
Nov 18, 2024 04:12AM
Nov 15, 2024 11:01AM Akero Therapeutics (AKRO) to Showcase New Analyses of Phase 2b HARMONY Study in Presentations at 75th Annual AASLD
Oct 20, 2024 10:00AM
Sep 17, 2024 06:50AM
Aug 9, 2024 08:29AM
Jun 12, 2024 07:44AM
Jun 11, 2024 05:02AM

409,092 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All